Avertus is a Canadian neurotechnology company composed of experienced business professionals, visionary academics, technological experts, and a talented engineering team. Our core competencies are in the areas of development, manufacturing, and commercialization of superior grade biomedical devices.
Founded in 2012 by an epileptologist and a neuronal algorithm expert in neural works and algorithm development, Avertus is a leading company researching algorithms for seizure detection to improve the treatment for patients with epilepsy.
Design, produce and support headsets for neurologists and clinical technicians to lower overall health care cost for treating neurological related diseases.
Avertus - Product Development Update (Q1 2015) from Avertus Inc.
Clinical signal-quality, mobile sensors
Electrode level pre-processing
Local referencing instead of central to localize noise
Dry electrode contact unaffected by hair
Sample up to 2,000 Hz per channel
Capture new features and patterns
Deploys in real time
Can be worn all day long without discomfort
Can be worn anywhere non-intrusively
Quick setup to start collecting signals in 1 minute
Significantly less cost than traditional EEG machines
Enable more patients to receive care
Increase profit margin for health care providers
Custom configurations with flexibility
Additional modality to adapt to different needs
Capable to incorporate stimulatory modules
Bluetooth auto-upload from sensor to device
Secure platform for storing, encrypting, processing and sharing data
Web-based, secure, mobile, real-time
Secure private cloud data management
Multi-tiered secure user access model
Strong encryption during transit and at rest
Fully compatible with major web browsers
Centralized updates reduce IT complexity
Real-time business intelligence engine
Headset integrates with mobile apps via Bluetooth
No device driver installation required
Collect, monitor and analzye in real-time anywhere
Video monitoring integrated with EEG
Avertus In The News
-Canadian Healthcare Technology Magazine
World class experience in biomedical technology management, research and product development
Doug is the founder and CEO of ZBx Corporation since 2002. In 1991, he co-founded Spectral Diagnostics Inc., the first Canadian biotech company to be listed on NASDAQ, National Markets. Under his management, many novel products have been successfully introduced into the market. Mr. Ball was a Vice President at Citibank Canada and a Representative with the Bank of Nova Scotia, New York.
MBA, CPA, CA, DVM; Patricia has senior level financial and operating experience in the software, food manufacturing, publishing, retail and wholesale distribution (including consumer products and medical devices) industries in Canada, the US and Latin America. She also has patenting and licensing experience. She is CPA and CGMA in the US and a CPA, CA and Dr. of Veterinary Medicine in Canada and an experienced angel investor.
Ron, the President of Avertus, has been actively involved in the formation and advances of the company since its inception. After completing his MBA at the Rotman School of Business at the University of Toronto, his passion turned to the business of product origination and realization. After completing his MBA at the Rotman School of Business at the University of Toronto, his passion turned to the business of product origination and realization.
Dr. Carlen is a clinical neurologist and epileptologist with over 35 years of expertise in the medical field (University of Toronto, University Health Network). He has the responsibility for integrating the software and analysis with patients, and providing neurological, neurobiological and expertise for experimental testing. Dr. Carlen is a Professor in the Department of Medicine, Division of Neurology, Toronto Western Hospital, the Department of Physiology, and the Institute of Biomaterials and Biomedical Engineering, University of Toronto.
Dr. Bardakjian is an electrical and biomedical engineer and Professor at the Institute of Biomaterials and Biomedical Engineering (University of Toronto). He is responsible for developing artificial neural networks and novel signal processing tools for pattern recognition to characterize brain states based on the integration of the fundamental concepts of physics, chemistry and biology within an engineering perspective.
An accomplished senior technologist having completed a broad range of projects designing and implementing enterprise information systems in the spaces of telecommunication, digital media and consumer products, Alex brings 10+ years of software and IT experience to the Avertus leadership team. Alex also completed his MBA at Wilfrid Laurier University specializing in management accounting, and holds a CPA, CMA designation.
Mirna is a biomedical engineer specializing in signal processing, machine learning, and brain state classification. She received a PhD from the University of Toronto in biomedical engineering with a focus on the spatiotemporal characterization of epileptic seizures.
Mohammad is an accomplished engineer with keen interest in developing new technologies and strong insight in multidisciplinary projects. He received a PhD in Electrical and Computer Engineering from McMaster University.
Kishan is a Biotech Mechanical Engineer with a degree in Mechatronics engineering from University of Waterloo. He is skilled at product design and has keen interest in designing biomedical devices.
Stelios is a computer scientist specializing in inter-clouds, future internet systems, clouds and in general with large scale distributed infrastructures. He received his PhD from the University of Derby in computer science, with a focus on inter-cloud meta-scheduling algorithms.
Louie is an expert server-side as well as web application developer wielding Spring, JavaEE, and proficient with several SQL database systems. His passion is full-stack application development, and also designs the various API's and is a core part of Avertus technology team.
Key problems Avertus is solving
Shortage in clinic space
Long waiting time - up to 18 months
Long setup time - 1 hr/patient
Disruptive for patient's lifestyle
Price prohibitive for most clinics to get more than one
Requires professional to setup, maintain and operate
Longer service turn-around
Trained technician required
Patient cannot self-monitor
Takes on average an hour to setup
Inconvenient for remote patients
Patients take device home, save clinic space
Low wait-time, first come first serve
Short setup time: 30 seconds to put on
Worn anywhere, no impact on patient's normal day-to-day
Low price compared to traditional EEG machines
No need for professional setup, maintain and operate
Very fast service turn-around
Patient can perform setup independently
Patient can self-monitor
Takes one minute to setup
Remote patients can transmit and share data with healthcare providers easily
Key Partners of Avertus
We look forward to hearing from you
Our headquarter is located in an industrial park 20 minutes north east of downtown Toronto, at Lawrence and Don Valley Parkway.